Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N8UY
|
||||
Former ID |
DIB010148
|
||||
Drug Name |
LY-686017
|
||||
Synonyms |
NK1 antagonist (anxiety/alcoholism), Eli Lilly
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alcohol use disorders [ICD9: 303; ICD10:F10.2] | Phase 2 | [521696] | ||
Company |
Eli Lilly & Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C28H16ClF6N5O
|
||||
Canonical SMILES |
c1(c(n(nn1)Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccncc1)c1c(C<br />(=O)c2c(Cl)cccc2)cccn1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Substance-P receptor | Target Info | Antagonist | [544119] | |
PANTHER Pathway | CCKR signaling map ST | ||||
Reactome | G alpha (q) signalling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.